Skip to main content

Research to Prevent Blindness Archives

RPB grant to support research, treatment of blinding diseases

Jul. 9, 2020—Research to Prevent Blindness (RPB) recently awarded a grant to investigators in Vanderbilt’s Department of Ophthalmology and Visual Sciences to support research into the causes, treatment and prevention of blinding diseases.

Read more


Insights on diabetic retinopathy

Jan. 23, 2020—A drug that targets multiple pathogenic steps in diabetic retinopathy may be an ideal therapeutic strategy for the disease, Vanderbilt researchers report.

Read more


Potassium balance and glaucoma

Jul. 15, 2019—Vanderbilt Eye Institute researchers have discovered that an imbalance in the ionic environment of retinal ganglion cells may contribute to functional impairments in glaucoma.

Read more


Research to Prevent Blindness awards grants to Department of Ophthalmology

Jul. 1, 2019—Vanderbilt Eye Institute receives grants to Research to study causes, treatment and prevention of blinding diseases.

Read more


Novel methods to treat glaucoma

Nov. 8, 2018—Increasing a certain signaling molecule prevents the degeneration of retinal cells that are lost in glaucoma, suggesting a new way to treat this disease.

Read more


Calkins lands innovation award from Research to Prevent Blindness

Jun. 28, 2018—Jun. 28, 2018—David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has been granted one of the preeminent awards in vision research — the Research to Prevent Blindness (RPB) Stein Innovation Award.

Read more


Two receive Research to Prevent Blindness grants

Jul. 21, 2016—Research to Prevent Blindness (RPB) has awarded two grants to faculty in the Department of Ophthalmology.

Read more


VEI receives grant from Research to Prevent Blindness for research and education

Jun. 25, 2015—The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000.

Read more


Retinal neuron survival in glaucoma

Dec. 16, 2014—Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions.

Read more


Biomarker for diabetic eye disease

Sep. 26, 2014—A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.

Read more


Keeping an eye on blast trauma

Aug. 19, 2014—Understanding the cellular and molecular responses of the eye to blast injury could guide new treatment development.

Read more


Protein boosts retinal neuron survival

Mar. 14, 2014—An ion channel protein called TRIPV1 helps retinal neurons survive the elevated eye pressure associated with glaucoma.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more